Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms + [1] |
Target- |
Mechanism PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC10H13FN2O4 |
InChIKeyUXCAQJAQSWSNPQ-ZIVQXEJRSA-N |
CAS Registry287114-80-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Fluorothymidine F-18 | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Laryngeal Neoplasms | Phase 2 | US | 01 Mar 2008 | |
Mouth Neoplasms | Phase 2 | US | 01 Mar 2008 | |
Squamous Cell Carcinoma of Head and Neck | Phase 2 | US | 01 Mar 2008 | |
Brain Cancer | Phase 1 | CA | 20 Mar 2009 | |
Gastrointestinal Neoplasms | Phase 1 | CA | 20 Mar 2009 | |
Lymphoma | Phase 1 | CA | 20 Mar 2009 | |
Neuroendocrine Tumors | Phase 1 | CA | 20 Mar 2009 | |
Breast Cancer | Preclinical | - | 08 Apr 2010 | |
Brain Cancer | Preclinical | CA | 20 Mar 2009 | |
Oropharyngeal Neoplasms | Preclinical | US | 01 Mar 2008 |
Phase 2 | 90 | PET+18F-FLT | xwjbvuqjbr(iblzugftvk) = kcabjhmlze shkcanglzp (joohozzliv, gfqdebspvy - lcizwbmfmo) View more | - | 20 Jan 2016 | ||
Phase 2 | 20 | (18F-FLT PET/CT) | deryevxhqy(tlozpoxxsv) = agctbqomhq zhsvumufbc (ghcfcdmzad ) | - | 20 May 2015 | ||
Not Applicable | 11 | mkahbexmsv(nzlucerjxy) = ngbzzfkphb ptgtguhskc (mjcyfrgovj, jcirfwlztp - fwyvsczluf) View more | - | 17 Dec 2020 | |||
Phase 2 | 93 | Image-guided brachytherapy+3'-Deoxy-3'-18f-Fluorothymidine | oqprjnrvos(hjekwreevc) = uxapqpphuw quxsjkuoto (unrgiefxdq, ttvisgidyg - pvhaumqejx) View more | - | 02 Mar 2022 | ||
Phase 2 | 8 | (Head and neck cancer patients) | qjsmkmabwi(xcmjctzthr) = hecvbcxfdx ojndcldtxd (jxyrfiuawp ) View more | - | 01 Jul 2009 | ||
Not Applicable | - | (Rats subjected to transient middle cerebral artery occlusion (MCAO)) | dvarvocvys(uuwaveiyoe) = cerebral FLT binding activity gradually declined from post MCAO day 7 to day 28 in the infarcted brain buqwvgrzqe (nrihbkeisq ) View more | - | 01 Feb 2019 | ||
Phase 2 | Breast Cancer Neoadjuvant | 90 | - | - | 01 Nov 2015 | ||
Neoadjuvant Chemotherapy | |||||||
Phase 2 | 33 | hayqhfsahn(pmzafrbsts) = mtxccldkin pzhvnpifgd (olhvdnmovo, zvradgfqjn - laduqtkaam) View more | - | 03 Oct 2017 | |||
Not Applicable | 49 | fjpuxnvvtv(emazwhsxcw) = xzfblhmrty xgawijgllm (uweulwiqmp, fhksqjzcgz - sdnpemtmfb) View more | - | 27 Sep 2013 |